enGene Therapeutics Inc 10-K for FY2025
enGene Therapeutics Inc. (ENGN)
10-K
2025-12-22
For: 2025-10-31
View Original
Added on
April 10, 2026
About this 10-K
enGene Therapeutics Inc filed this 10-K on December 22, 2025, covering the fiscal year ended October 31, 2025 (FY2025).
Headline figures
Fiscal year ended October 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $117.3M
- compared with a net loss of $55.14M a year earlier
- Diluted EPS
- $2.29
- up 56.8% from $1.46 a year earlier